Case Study: Global Pharmaceutical Company eliminates FDA re-submission costs and unifies ECMs with Adlib Software

Eliminate FDA Re-Submission Costs and Unify ECMs

Global Pharmaceutical Company faced costly FDA resubmission errors—each resubmission cost ~$250K and caused 30–60 day delays—caused by incompatible, distributed document management systems, large unwieldy files, and high-volume intake (about 1,500 emails/day and 4,500 pages/week). To address this, the company engaged Adlib Software and its Advanced Rendering technology/Adlib PDF Enterprise to standardize and shrink files for mobile readability and unified ECM interoperability.

Adlib Software implemented server-side rendering to high‑fidelity, locked PDF output, creating a single point of management with high availability and failover, eliminating manual workflows and enabling field access and full-text search. As a result, the Global Pharmaceutical Company decommissioned its costly legacy solution, demonstrated records-retention compliance, secured content, and gained scalable processing capacity—removing the root causes of FDA resubmissions and reducing associated costs and delays.